Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07099131 · ClinicalTrials.gov registry record · Early Phase 1
Effective Interventions to Overcome Severe Gag Reflex
A Early Phase 1 study, sponsored by Tufts University.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 45
- Enrollment target
NCT07099131 is a Early Phase 1 study that has not yet begun recruiting, run by Tufts University. The registered enrollment target is 45 participants.
The verdict
NCT07099131, a Early Phase 1 study, has not yet begun recruiting, sponsored by Tufts University.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of various techniques in alleviating gag reflex following gag reflex stimulation. Primary aim: To compare if there is any reduction in gag reflex from each of the following interventions * Acupuncture (CV-24) * Tape * Anesthetic spray Secondary aim: to compare the degree of gag reduction
Interventions
- DEVICE Acupuncture
- DRUG Anesthetic spray
- GENETIC Masking Tape
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-12-07 |
| Est. Completion | 2028-12-07 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07099131
The ClinicalTrials.gov registry entry for NCT07099131 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acupuncture is the first listed.
NCT07099131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07099131 about?
NCT07099131 is a clinical study titled "Effective Interventions to Overcome Severe Gag Reflex". The purpose of this study is to evaluate the use of various techniques in alleviating gag reflex following gag reflex stimulation. Primary aim: To compare if there is any reduction in gag reflex from each of the following interventions * Acupuncture (CV-24) * Tape * Anesthetic spray Secondary aim:...
What is the current status of trial NCT07099131?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2025-12-07. Estimated completion is 2028-12-07.
What interventions are being tested in trial NCT07099131?
The interventions under investigation include: Acupuncture (DEVICE), Anesthetic spray (DRUG), Masking Tape (GENETIC).
Who is sponsoring clinical trial NCT07099131?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.